Free Trial

NFJ Investment Group LLC Sells 4,402 Shares of MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

NFJ Investment Group LLC trimmed its position in MetLife, Inc. (NYSE:MET - Free Report) by 4.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 103,541 shares of the financial services provider's stock after selling 4,402 shares during the period. NFJ Investment Group LLC's holdings in MetLife were worth $8,478,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. United Asset Strategies Inc. raised its position in shares of MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock worth $895,000 after purchasing an additional 120 shares during the period. Barrett & Company Inc. lifted its stake in MetLife by 1.0% in the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock worth $978,000 after acquiring an additional 121 shares in the last quarter. J.W. Cole Advisors Inc. grew its stake in MetLife by 2.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider's stock valued at $495,000 after acquiring an additional 126 shares in the last quarter. Davis R M Inc. lifted its position in shares of MetLife by 4.2% in the fourth quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider's stock worth $258,000 after purchasing an additional 127 shares in the last quarter. Finally, Daymark Wealth Partners LLC grew its position in MetLife by 3.0% during the fourth quarter. Daymark Wealth Partners LLC now owns 5,091 shares of the financial services provider's stock valued at $417,000 after purchasing an additional 149 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on MET. Piper Sandler lifted their price objective on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Barclays decreased their price objective on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. BMO Capital Markets began coverage on MetLife in a report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price on the stock. Wells Fargo & Company reduced their price objective on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Finally, JPMorgan Chase & Co. decreased their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $92.46.

Get Our Latest Research Report on MET

MetLife Trading Up 2.3 %

Shares of NYSE:MET traded up $1.65 during midday trading on Tuesday, reaching $72.05. The company's stock had a trading volume of 913,829 shares, compared to its average volume of 3,803,949. The firm has a market capitalization of $49.08 billion, a price-to-earnings ratio of 12.06, a PEG ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The firm has a 50 day moving average price of $78.94 and a two-hundred day moving average price of $82.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines